AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 122 min read$ARCB

Anderson Dennis L II sold $737K of ARCB

Anderson Dennis L II (Chief Innovation Officer) sold 5,450 shares of ARCBEST CORP /TX/ (ARCB) at an average of $135.16 ($134.87–$135.63, $0.74M total) across 2 trades on 2026-08-11.

Original reporting
SEC EDGAR · Anderson Dennis L II
Published Aug 12, 2026, 8:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ARCB
Neutral
low confidence
Mentioned
$ARCB
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARCBNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this disclosure alone does not change company cash flows, guidance, or risk materially.

02

Market read

A disclosed insider sale of about $0.74M in ARCB shares, with no accompanying fundamental news.

03

What to watch

The filing does not state motivations, whether sales were part of broader diversification, or whether other insiders/large holders acted similarly around the same time.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-12 after 2026-08-11 sale

Background

The article is an SEC Form 4 insider transaction report for ARCB, filed the day after the sale date.

Company-level read

Ticker impact

$ARCBNeutralLow confidence
Context

ARCB insider Anderson Dennis L II sold $736,639 of ARCB shares via open-market transactions on 2026-08-11.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 shows an officer sale (5,450 shares) with a stated price range, but the filing does not include earnings, guidance, contracts, or regulatory actions that would reset valuation.

Market effects

Sector

No clear sector read-through from a single insider sale disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be pre-planned for liquidity or tax needs; absence of a 10b5-1 label here does not necessarily imply negative expectations.

Key entities

  • issuer
    ARCBEST CORP

    Company whose insider transaction is reported on SEC Form 4.

  • insider
    Anderson Dennis L II

    Chief Innovation Officer who sold 5,450 shares of ARCB on 2026-08-11.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARCB insider trading history →

Related articles

AUG 5
$ARCBMed

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

financialcontent.com4 min
AUG 1
$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

yahoo.com6 min
JUL 31
$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

yahoo.com5 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$ARCBMedAI 8/10

ArcBest’s Q2 a step on path to recovery

ArcBest's second-quarter results showed operational improvements in both of its business segments. It is benefitting from heavier shipment weights on the asset-based side of the house while cost initiatives have pushed its logistics offering back into profitability. Shipment weights increasing as TL freight returns ArcBest's (NASDAQ: ARCB) asset-based unit, which includes less-than-truckload subsidiary ABF Freight, reported a 10% y/y increase in revenue to $784 million.

yahoo.com4 min
JUL 29
$ARCBMed

ArcBest reports second quarter loss, affected by restructuring costs | Arkansas Democrat Gazette

ArcBest reported a Q2 GAAP loss of $13.8 million, or 62 cents per share, versus a year-ago profit of $25.8 million, or $1.12 per share. Revenue rose to $1.18 billion from $1.02 billion. Non-GAAP net income was $53.6 million, or $2.38 per diluted share. The results were tied to restructuring costs from a July 16 plan and included $40 million annualized savings.

arkansasonline.com6 min